Labial herpes: view on the problem, options for optimizing topical therapy

2019 ◽  
Vol 0 (3) ◽  
pp. 87-91
Author(s):  
A.S. Chernovol
Keyword(s):  
1994 ◽  
Vol 56 (1) ◽  
pp. 105-108 ◽  
Author(s):  
Hiroshi HACHISUKA ◽  
Osamu MORI ◽  
Tomoyuki MAEDA ◽  
Yoichiro SASAI
Keyword(s):  

1997 ◽  
Vol 59 (2) ◽  
pp. 222-226 ◽  
Author(s):  
Naruhisa NISHIYAMA ◽  
Hideki NODA ◽  
Kenro TSUBOI

2003 ◽  
Vol 65 (4) ◽  
pp. 331-332
Author(s):  
Hiroshi HAMADA ◽  
Takurou KANEKURA ◽  
Tamotsu KANZAKI

2015 ◽  
Vol 21 (19) ◽  
pp. 2643-2667 ◽  
Author(s):  
Lin Sun ◽  
Zeyu Liu ◽  
Dongmei Cun ◽  
Henry Tong ◽  
Ying Zheng

2020 ◽  
Vol 15 (4) ◽  
pp. 283-298
Author(s):  
Suresh Kumar Sahu ◽  
Rakesh Raj ◽  
Pooja Mongia Raj ◽  
Ram Alpana

Treatment of skin ailments through systemic administration is limited due to toxicity and patients discomfort. Hence, lower risk of systemic side effects from topical dosage forms like ointments, creams, emulsions and gels is more preferred for the treatment of skin disease. Application of lipid based carriers in drug delivery in topical formulations has recently become one of the major approaches to improve drug permeation, safety, and effectiveness. These delivery systems include liposomes, ethosomes, transfersomes, Nanoemulsions (NEs), Solid Lipid Nanoparticles (SLNs) Nanostructured Lipid Carriers (NLCs) and micelles. Most of the liposomes and SLNs based products are in the market while some are under investigation. Transcutaneous delivery of therapeutics to the skin layer by novel lipid based carriers has enhanced topical therapy for the treatment of skin ailments. This article covers an overview of the lipid-based carriers for topical uses to alleviate skin diseases.


Sign in / Sign up

Export Citation Format

Share Document